44 related articles for article (PubMed ID: 16951943)
1.
Padula MC; Padula AA; D'Angelo S; Lascaro N; Radice RP; Martelli G; Leccese P
J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763115
[TBL] [Abstract][Full Text] [Related]
2. The association between TNF-α 238A/G and 308A/G polymorphisms and juvenile idiopathic arthritis: An updated PRISMA-compliant meta-analysis.
Li XY; Liang CH; Parkman V; Lv ZT
Medicine (Baltimore); 2018 Oct; 97(43):e12883. PubMed ID: 30412082
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.
Hersh AO; Prahalad S
J Autoimmun; 2015 Nov; 64():113-24. PubMed ID: 26305060
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
Schmeling H; Horneff G; Benseler SM; Fritzler MJ
Nat Rev Rheumatol; 2014 Nov; 10(11):682-90. PubMed ID: 25112604
[TBL] [Abstract][Full Text] [Related]
6. TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?
Scardapane A; Breda L; Lucantoni M; Chiarelli F
Int J Rheumatol; 2012; 2012():756291. PubMed ID: 23133455
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of etanercept in rheumatoid arthritis.
Danila MI; Hughes LB; Bridges SL
Pharmacogenomics; 2008 Aug; 9(8):1011-5. PubMed ID: 18681777
[TBL] [Abstract][Full Text] [Related]
8. IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors.
Cimaz R; Cazalis MA; Reynaud C; Gerloni V; Zulian F; Biggioggero M; Martini G; Pontikaki I; Fantini F; Mougin B; Miossec P
Ann Rheum Dis; 2007 Jul; 66(7):900-4. PubMed ID: 17324969
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan.
Yokota S; Mori M; Imagawa T; Murata T; Tomiita M; Itoh Y; Fujikawa S; Takei S;
Mod Rheumatol; 2010 Apr; 20(2):107-13. PubMed ID: 20087751
[TBL] [Abstract][Full Text] [Related]
10. Etanercept in juvenile rheumatoid arthritis.
Johnson CJ; Reilly KM; Murray KM
Ann Pharmacother; 2001 Apr; 35(4):464-71. PubMed ID: 11302411
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis.
Schmeling H; Horneff G
Rheumatol Int; 2007 Feb; 27(4):383-6. PubMed ID: 16951943
[TBL] [Abstract][Full Text] [Related]
12. Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Basic J; Pavlovic D; Jevtovic-Stoimenov T; Vojinovic J; Susic G; Stojanovic I; Kocic G; Milosevic V; Cvetkovic T; Marinkovic M; Veljkovic A
J Physiol Biochem; 2010 Jun; 66(2):173-80. PubMed ID: 20596903
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis.
Schmeling H; Wagner U; Peterson A; Horneff G
Clin Exp Rheumatol; 2006; 24(1):103-8. PubMed ID: 16539828
[TBL] [Abstract][Full Text] [Related]
14. TNF-α gene polymorphisms and juvenile idiopathic arthritis: Influence on disease outcome and therapeutic response.
Scardapane A; Ferrante R; Nozzi M; Savino A; Antonucci I; Dadorante V; Balsamo M; Stuppia L; Chiarelli F; Breda L
Semin Arthritis Rheum; 2015 Aug; 45(1):35-41. PubMed ID: 25837015
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]